PGP and cancer: The lysosomal sequestration of doxorubicin in cancer cells was reported to be dependent on Pgp activity, as an inhibition of Pgp drug transport by Pgp inhibitors (elacridar, valspodar) or siRNA led to a loss of lysosomal sequestration of doxorubicin [132].